Abstract
Pluripotent stem cells (PSCs), including embryonic stem cells and induced pluripotent stem cells, show heterogeneity with respect to their pluripotency, self-renewal ability, and other traits. PSC heterogeneity may exist among cell lines, among cells within a line, and among temporal states of individual cells. Both genetic and epigenetic factors can cause heterogeneity among cell lines. Heterogeneity among cells within a cell line may arise during long-term culturing even when a PSC cell line is derived from a single cell. Moreover, the expression levels of genes and proteins in PSCs fluctuate continuously at a frequency ranging from a few hours to a few days. Such heterogeneity decreases the reproducibility of research. Thus, methods related to the detection, reduction, and control of heterogeneity in experiments involving human PSCs need to be developed. Further, the presupposition that PSCs are highly heterogeneous should be taken into account by all researchers not only when they plan their own studies but also when they review the studies of other researchers in this field.
Author contributions: Sections “Genetic Variability Among PSC Types,” “Epigenetic Differences Among PSC Lines” and “Heterogeneity Among Each Cell in a Cell Line,”(YH); Sections “Introduction,” “Temporal Fluctuation of PSCs,” and “Perspective and Conclusion” (KO), Sections “Imaging Methods for Detecting PSC Heterogeneity” and “Quality control of heterogeneous hPSCs” (MKF).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cahan P, Daley GQ (2013) Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol 14:357–368
Fakunle ES, Loring JF (2012) Ethnically diverse pluripotent stem cells for drug development. Trends Mol Med 18:709–716
Kajiwara M et al (2012) Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A 109:12,538–12,543
Howden SE et al (2011) Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci U S A 108:6537–6542
Gore A et al (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471:63–67
Quinlan AR et al (2011) Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell 9:366–373
Abyzov A et al (2012) Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492:438–442
Cheng L et al (2012) Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 10:337–344
Young MA et al (2012) Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell 10:570–582
Liang G, Zhang Y (2013) Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13:149–159
Hayashi Y (2017) Human mutations affecting reprogramming into induced pluripotent stem cells. AIMS Cell Tissue Eng 1:31–46
Kinoshita T et al (2011) Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells. Biochem Biophys Res Commun 407:321–326
Nayler S et al (2012) Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype. Stem Cells Transl Med 1:523–535
Fukawatase Y et al (2014) Ataxia telangiectasia derived iPS cells show preserved x-ray sensitivity and decreased chromosomal instability. Sci Rep 4:5421
Zhang J et al (2011) A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8:31–45
Liu GH et al (2011) Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472:221–225
Agarwal S et al (2010) Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464:292–296
Winkler T et al (2013) Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs. J Clin Invest 123:1952–1963
Batista LF et al (2011) Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474:399–402
Yokota M, Hatakeyama H, Okabe S, Ono Y, Goto Y (2015) Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming. Hum Mol Genet 24:4698–4709
Zhou Y et al (2017) Mitochondrial spare respiratory capacity is negatively correlated with nuclear reprogramming efficiency. Stem Cells Dev 26:166–176
Hung SS et al (2016) Study of mitochondrial respiratory defects on reprogramming to human induced pluripotent stem cells. Aging (Albany NY) 8:945–957
Bershteyn M et al (2014) Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells. Nature 507:99–103
Yu Y et al (2015) Chromosome microduplication in somatic cells decreases the genetic stability of human reprogrammed somatic cells and results in pluripotent stem cells. Sci Rep 5:10,114
Hamasaki M et al (2012) Pathogenic mutation of Alk2 inhibits ips cell reprogramming and maintenance: mechanisms of reprogramming and strategy for drug identification. Stem Cells 30:2437–2449
Hayashi Y et al (2016) BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence. Proc Natl Acad Sci U S A 113:13,057–13,062
Tanaka T et al (2012) Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery. Blood 120:1299–1308
Ji J et al (2012) Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells 30:435–440
Sugiura M et al (2014) Induced pluripotent stem cell generation-associated point mutations arise during the initial stages of the conversion of these cells. Stem Cell Rep 2:52–63
Yoshihara M et al (2017) Hotspots of de novo point mutations in induced pluripotent stem cells. Cell Rep 21:308–315
Rouhani FJ et al (2016) Mutational history of a human cell lineage from somatic to induced pluripotent stem cells. PLoS Genet 12:e1005932
Bhutani K et al (2016) Whole-genome mutational burden analysis of three pluripotency induction methods. Nat Commun 7:10,536
Mandai M et al (2017) Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med 376:1038–1046
Thomson JA et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
Takahashi K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
Yu J et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920
Mallon BS et al (2014) Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin. Stem Cell Res 12:376–386
Koyanagi-Aoi M et al (2013) Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci U S A 110:20569–20574
Riera M et al (2016) Comparative study of human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) as a treatment for retinal dystrophies. Mol Ther Methods Clin Dev 3:16010
Brons IG et al (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448:191–195
Tesar PJ et al (2007) New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448:196–199
Smith AG et al (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336:688–690
Williams RL et al (1988) Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336:684–687
Furue M et al (2005) Leukemia inhibitory factor as an anti-apoptotic mitogen for pluripotent mouse embryonic stem cells in a serum-free medium without feeder cells. In Vitro Cell Dev Biol Anim 41:19–28
Ying QL et al (2008) The ground state of embryonic stem cell self-renewal. Nature 453:519–523
Li Y, Powell S, Brunette E, Lebkowski J, Mandalam R (2005) Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng 91:688–698
Amit M, Shariki C, Margulets V, Itskovitz-Eldor J (2004) Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 70:837–845
Sumi T, Fujimoto Y, Nakatsuji N, Suemori H (2004) STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells. Stem Cells 22:861–872
Daheron L et al (2004) LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22:770–778
Humphrey RK et al (2004) Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 22:522–530
Hanna J et al (2010) Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A 107:9222–9227
Buecker C et al (2010) A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. Cell Stem Cell 6:535–546
Hu Z et al (2015) Generation of naivetropic induced pluripotent stem cells from parkinson’s disease patients for high-efficiency genetic manipulation and disease modeling. Stem Cells Dev 24:2591–2604
Zimmerlin L et al (2016) Tankyrase inhibition promotes a stable human naive pluripotent state with improved functionality. Development 143:4368–4380
Chen H et al (2015) Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency. Nat Commun 6:7095
Tomoda K et al (2012) Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell 11:91–99
Pera MF, Tam PP (2010) Extrinsic regulation of pluripotent stem cells. Nature 465:713–720
Yang J et al (2017) Establishment of mouse expanded potential stem cells. Nature 550:393–397
Kim K et al (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467:285–290
Nazor KL et al (2012) Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 10:620–634
Bar-Nur O, Russ HA, Efrat S, Benvenisty N (2011) Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9:17–23
Pomp O et al (2011) Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell 9:156–165
Zhao MT et al (2017) Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs. Proc Natl Acad Sci U S A 114:E11111–E11120
Yanagihara K et al (2016) Prediction of differentiation tendency toward hepatocytes from gene expression in undifferentiated human pluripotent stem cells. Stem Cells Dev 25:1884–1897
Wen L, Tang F (2016) Single-cell sequencing in stem cell biology. Genome Biol 17:71
The International Stem Cell Initiative (2011) Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 29:1132–1144
Avery S et al (2013) BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Rep 1:379–386
Peterson SE et al (2011) Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy. PLoS One 6:e23018
Dekel-Naftali M et al (2012) Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q. Eur J Hum Genet 20:1248–1255
Narva E et al (2010) High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 28:371–377
Tesarova L, Simara P, Stejskal S, Koutna I (2016) The aberrant DNA methylation profile of human induced pluripotent stem cells is connected to the reprogramming process and is normalized during in vitro culture. PLoS One 11:e0157974
Singh AM (2015) Cell cycle-driven heterogeneity: on the road to demystifying the transitions between “poised” and “restricted” pluripotent cell states. Stem Cells Int 2015:219514
Dalton S (2015) Linking the cell cycle to cell fate decisions. Trends Cell Biol 25:592–600
Mitsui K et al (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631–642
Chambers I et al (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643–655
The International Stem Cell Initiative (2007) Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25:803–816
Hatano S-Y et al (2005) Pluripotential competence of cells associated with Nanog activity. Mech Dev 122:67–79
Wu J, Tzanakakis ES (2012) Contribution of stochastic partitioning at human embryonic stem cell division to NANOG heterogeneity. PLoS One 7:e50715
Chambers I et al (2007) Nanog safeguards pluripotency and mediates germline development. Nature 450:1230–1234
van den Berg DL et al (2008) Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression. Mol Cell Biol 28:5986–5995
Frieda KL et al (2017) Synthetic recording and in situ readout of lineage information in single cells. Nature 541:107–111
Filipczyk A et al (2015) Network plasticity of pluripotency transcription factors in embryonic stem cells. Nat Cell Biol 17:1235–1246
Toyooka Y, Shimosato D, Murakami K, Takahashi K, Niwa H (2008) Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 135:909–918
Kobayashi T et al (2009) The cyclic gene Hes1 contributes to diverse differentiation responses of embryonic stem cells. Genes Dev 23:1870–1875
Hayashi K, de Sousa Lopes SMC, Tang F, Surani MA (2008) Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 3:391–401
Falco G et al (2007) Zscan4: a novel gene expressed exclusively in late 2-cell embryos and embryonic stem cells. Dev Biol 307:539–550
Zalzman M et al (2010) Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature 464:858–863
Amano T et al (2013) Zscan4 restores the developmental potency of embryonic stem cells. Nat Commun 4:1966
Nakai-Futatsugi Y, Niwa H (2016) Zscan4 is activated after telomere shortening in mouse embryonic stem cells. Stem Cell Rep 6:483–495
Yamanaka Y, Lanner F, Rossant J (2010) FGF signal-dependent segregation of primitive endoderm and epiblast in the mouse blastocyst. Development 137:715–724
Nakamura T et al (2016) A developmental coordinate of pluripotency among mice, monkeys and humans. Nature 537:57
Bhadriraju K et al (2016) Large-scale time-lapse microscopy of Oct4 expression in human embryonic stem cell colonies. Stem Cell Res 17:122–129
Morgani SM et al (2013) Totipotent embryonic stem cells arise in ground-state culture conditions. Cell Rep 3:1945–1957
Pauklin S, Vallier L (2013) The cell-cycle state of stem cells determines cell fate propensity. Cell 155:135–147
Hough SR et al (2014) Single-cell gene expression profiles define self-renewing, pluripotent, and lineage primed states of human pluripotent stem cells. Stem Cell Rep 2:881–895
Eldar A, Elowitz MB (2010) Functional roles for noise in genetic circuits. Nature 467:167–173
Furusawa C, Kaneko K (2012) A dynamical-systems view of stem cell biology. Science 338:215–217
Semrau S et al (2017) Dynamics of lineage commitment revealed by single-cell transcriptomics of differentiating embryonic stem cells. Nat Commun 8:1096
Macfarlan TS et al (2012) Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature 487:57–63
Abranches E et al (2014) Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. Development 141:2770–2779
Smith RCG et al (2017) Nanog fluctuations in embryonic stem cells highlight the problem of measurement in cell biology. Biophys J 112:2641–2652
Nakamura S et al (2018) Asymmetry between sister cells of pluripotent stem cells at the onset of differentiation. Stem Cells Dev 27:347–354
Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448:313–317
Na J, Baker D, Zhang J, Andrews PW, Barbaric I (2014) Aneuploidy in pluripotent stem cells and implications for cancerous transformation. Protein Cell 5:569–579
Laurent LC et al (2011) Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8:106–118
Amit M, Itskovitz-Eldor J (2011) Atlas of human pluripotent stem cells derivation and culturing. Humana Press, New York, pp 15–39
Kato R et al (2016) Parametric analysis of colony morphology of non-labelled live human pluripotent stem cells for cell quality control. Sci Rep 6:34009
Chan EM et al (2009) Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27:1033–1037
Pfannkuche K, Fatima A, Gupta MK, Dieterich R, Hescheler J (2010) Initial colony morphology-based selection for iPS cells derived from adult fibroblasts is substantially improved by temporary UTF1-based selection. PLoS One 5:e9580
Wakao S et al (2012) Morphologic and gene expression criteria for identifying human induced pluripotent stem cells. PLoS One 7:e48677
Gu M et al (2012) Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation. Circ Res 111:882–893
Tokunaga K et al (2014) Computational image analysis of colony and nuclear morphology to evaluate human induced pluripotent stem cells. Sci Rep 4:6996
Matsuoka F et al (2013) Morphology-based prediction of osteogenic differentiation potential of human mesenchymal stem cells. PLoS One 8:e55082
Matsuoka F et al (2014) Characterization of time-course morphological features for efficient prediction of osteogenic potential in human mesenchymal stem cells. Biotechnol Bioeng 111:1430–1439
Maddah M, Loewke K (2014) Automated, non-invasive characterization of stem cell-derived cardiomyocytes from phase-contrast microscopy. Med Image Comput Comput Assist Interv 17:57–64
Suga M, Kii H, Niikura K, Kiyota Y, Furue MK (2015) Development of a monitoring method for nonlabeled human pluripotent stem cell growth by time-lapse image analysis. Stem Cells Transl Med 4:720–730
The International Stem Cell Banking Initiative (2009) Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev 5:301–314
Suga M, Tachikawa S, Tateyama D, Ohnuma K, Furue MK (2017) Imaging-cytometry revealed spatial heterogeneities of marker expression in undifferentiated human pluripotent stem cells. In Vitro Cell Dev Biol Anim 53:83–91
Draper JS et al (2004) Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22:53–54
Harrison NJ, Baker D, Andrews PW (2007) Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int J Androl 30:275–281. discussion 281
Enver T et al (2005) Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet 14:3129–3140
Hyka-Nouspikel N et al (2012) Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cells. Stem Cells 30:1901–1910
Barbaric I et al (2014) Time-lapse analysis of human embryonic stem cells reveals multiple bottlenecks restricting colony formation and their relief upon culture adaptation. Stem Cell Rep 3:142–155
The International Stem Cell Banking Initiative (2015) Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regen Med 10:1–44
Eliceiri KW et al (2012) Biological imaging software tools. Nat Methods 9:697–710
Chieco P, Jonker A, De Boer BA, Ruijter JM, Van Noorden CJ (2013) Image cytometry: protocols for 2D and 3D quantification in microscopic images. Prog Histochem Cytochem 47:211–333
O’Connor MD et al (2008) Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells 26:1109–1116
Moralli D et al (2011) An improved technique for chromosomal analysis of human ES and iPS cells. Stem Cell Rev 7:471–477
Anguiano A et al (2012) Spectral Karyotyping for identification of constitutional chromosomal abnormalities at a national reference laboratory. Mol Cytogenet 5:3
Das K, Tan P (2013) Molecular cytogenetics: recent developments and applications in cancer. Clin Genet 84:315–325
The International Stem Cell Initiative (2018) Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells. Nat Commun 9:1925
Tsankov AM et al (2015) A qPCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells. Nat Biotechnol 33:1182
Bock C et al (2011) Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144:439–452
Ng ES, Davis RP, Azzola L, Stanley EG, Elefanty AG (2005) Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 106:1601–1603
Coecke S et al (2005) Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice. Altern Lab Anim 33:261–287
OECD. Draft Guidance Document on Good In Vitro Method Practices (GIVIMP) for the Development and Implementation of In Vitro Methods for Regulatory Use in Human Safety Assessment, 2018
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hayashi, Y., Ohnuma, K., Furue, M.K. (2019). Pluripotent Stem Cell Heterogeneity. In: Birbrair, A. (eds) Stem Cells Heterogeneity - Novel Concepts. Advances in Experimental Medicine and Biology, vol 1123. Springer, Cham. https://doi.org/10.1007/978-3-030-11096-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-11096-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11095-6
Online ISBN: 978-3-030-11096-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)